Delivery Order SPE2DB22D2206-SPE2DB25FHT93
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules, with a ceiling value of $5,698.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This...
- The Defense Logistics Agency awarded a $1,376.87 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Methylphenidate ER (CD) 50mg capsules (100 count) valued at $1,716.02. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.28 for Methylphenidate ER(LA) 10mg capsules (100-count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,987.51 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Methylphenidate ER(LA) 20mg capsules (100 count) with a ceiling value of $1,421.35. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and running through December 2026. The delivery order was competitively awarded with no set-aside designation and is...
- The Defense Logistics Agency awarded a $1,212.28 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Methylphenidate Extended-Release 10mg capsules (100-count). This is a firm fixed price delivery order with no set-aside designation, exercised under a competitive procurement process. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This award represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules. This competitively awarded, non-set-aside contract carries a ceiling value of $1,652.20 and is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,130.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 30mg capsules (100-count units). This contract award, executed on August 4, 2025, with completion targeted for August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHT93Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units) with a ceiling value of $2,917.54. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 8, 2025. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and broader military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications across multiple therapeutic domains through its $999,999,999.00 global pharmaceutical support IDC with DLA, which runs through December 2026. The company's federal contract portfolio demonstrates its established capability to fulfill diverse medical supply requirements for military and veteran healthcare programs, positioning it as a key vendor within the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/7/25 |